Clinigen launches ‘What is Possible?’ campaign to accelerate access to medicines on Rare Disease Day With over 7,000 rare diseases that impact over 300 million people globally, just 5% of rare diseases have a licensed treatment LONDON, UK, 29 February 2024 – Clinig.
Clinigen launches NaviGATE: an educational programme for rare disease patients and organisations tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.
Investegate announcements from Clinigen, Clinigen notes results from the MIROCALS trial investigating low dose Proleukin® (aldesleukin) in patients with amyotrophic lateral sclerosis
8 December 2022 Clinigen notes results from the MIROCALS trial investigating low dose Proleukin (aldesleukin) in patients with amyotrophic lateral sclerosis Clinigen Limited